While Amphastar Pharmaceuticals Inc has overperformed by 2.47%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AMPH fell by -25.05%, with highs and lows ranging from $49.12 to $20.39, whereas the simple moving average jumped by 5.77% in the last 200 days.
On August 12, 2025, Needham Upgraded Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) to Buy. A report published by JP Morgan on May 12, 2025, Downgraded its rating to ‘Neutral’ for AMPH. Piper Sandler also Downgraded AMPH shares as ‘Neutral’, setting a target price of $36 on the company’s shares in a report dated February 04, 2025. Wells Fargo Initiated an Equal Weight rating on November 22, 2024, and assigned a price target of $55. JP Morgan initiated its ‘Overweight’ rating for AMPH, as published in its report on March 05, 2024. BofA Securities’s report from November 17, 2023 suggests a price prediction of $63 for AMPH shares, giving the stock a ‘Neutral’ rating. Jefferies also rated the stock as ‘Buy’.
Analysis of Amphastar Pharmaceuticals Inc (AMPH)
Further, the quarter-over-quarter increase in sales is 0.33%, showing a positive trend in the upcoming months.
In order to gain a clear picture of Amphastar Pharmaceuticals Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of 14.84% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.21, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 468.81K can be a very valuable indicator of volatility for AMPH stock. On a monthly basis, the volatility of the stock is set at 4.56%, whereas on a weekly basis, it is put at 9.15%, with a gain of 9.96% over the past seven days. Furthermore, long-term investors anticipate a median target price of $32.00, showing growth from the present price of $27.83, which can serve as yet another indication of whether AMPH is worth investing in or should be passed over.
How Do You Analyze Amphastar Pharmaceuticals Inc Shares?
The USA based company Amphastar Pharmaceuticals Inc (AMPH) is one of the biggest names in Drug Manufacturers – Specialty & Generic. When comparing Amphastar Pharmaceuticals Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 12.34, there is a growth in quarterly earnings of -53.32%.
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 26.39%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 71.55% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
